MAKO Surgical Corp. Reports Operating Results for the First Quarter 2012 and $50 Million Debt Funding Commitment

Published: May 08, 2012

FORT LAUDERDALE, FL, May 7, 2012 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets its RIO® Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty® joint specific applications, and proprietary RESTORIS® implants that together enable orthopedic surgeons to consistently, reproducibly and precisely treat patient specific osteoarthritic disease, today announced its operating results for the quarter ended March 31, 2012.

Back to news